
About Elucid
Elucid is a Healthcare company based in Boston (United States) founded in 2013 by James Hamilton and Andrew J Buckler. AI-based arterial analysis software is developed for clinical providers. Elucid has raised $206.87 million across 8 funding rounds from investors including Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners. Its chief executive, as recorded, is Blake Richards. Its focus areas include HealthTech, Healthcare IT, Provider and Clinical Operations. Its legal entity is ELUCID BIOIMAGING INC. Its competitors include Vista.ai and Dyad Medical; 1 of its 2 listed competitors has raised funding.
Company details
Elucid was founded in 2013 and is headquartered in Boston, United States. AI-driven software for arterial analysis is provided to healthcare providers, supporting clinical diagnostic processes. Features are included for clinical research, personalized patient care, and stroke prediction. Operations focus on medical imaging and diagnostic tools within the health technology sector.
- Headquarters Boston, United States
- Founders James Hamilton, Andrew J Buckler
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website elucid.com
- Social LinkedIn X YouTube
- Legal Name Elucid Bioimaging Inc.
- Total Equity Funding$206.87M (USD)
in 8 rounds
- Latest Funding Round$55M (USD), Series D
Sep 2026
- InvestorsElevage Medical Technologies
& 8 more
Apps and channels of Elucid
its YouTube channel Elucid has 86 subscribers and 30 videos.
Videos from Elucid
The most watched videos on Elucid's YouTube channel, Elucid (86 subscribers). Click a video to play it here.
More on Elucid.
Funding Insights of Elucid
Elucid has successfully raised a total of $206.87M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $55 million completed in September 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $206.87M
- Total Rounds 8
- Last Round Series D β $55M
- First Round $375,000
(Aug 2013)
- Investors Count 9
All 8 funding rounds of Elucid with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2026 | $55M | Series D | β | β | |
| Oct 2025 | $36.5M | Series C | β | β | β |
| Oct 2023 | $80M | Series C | β | Elevage Medical Technologies | β |
| Jun 2022 | $27M | Series B | β | β | |
| May 2021 | $8M | Series A | β | β | |
| Sep 2015 | $4.57M | Grant | β | β | |
| Apr 2014 | $1.35M | Grant | β | β | |
| Aug 2013 | $375,000 | Seed | β | β | β |
9 investors in total: 9 institutional.
Investors in Elucid
Elucid has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Elevage Medical Technologies, MedTex Ventures and IAG Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| medtexventures.com | ||||
Venture capital investments are provided by IAG Capital Partners. | iagcapitalpartners.com | Charleston, USA | ||
| bluestonevp.com | ||||
Biovision Ventures is focused on investing in life sciences and healthcare innovations. | biovision.vc | Luxembourg, Luxembourg | ||
Bold Brain Capital is focused on AI healthcare investments. | boldbrain.vc | Durham, United States | ||
| elevagemedical.com | ||||
Elevage Medical Technologies is focused on supporting medtech innovation. | elevagemedicaltechnologies.com | Austin, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States | |
Venture capital investments are made in early-stage healthcare startups. | globalhealthimpactfund.com | San Ramon, USA |
Investor details for Elucid
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Elucid
13 people are tracked at Elucid (7 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
James Hamilton | Co-Founder | Leadership |
Andrew J Buckler | Co-Founder & President | Leadership |
Blake Richards | CEO | Leadership |
John Sukumar Aluru | Director Clinical Development- Imaging | Leadership |
Shruti Choudhary M.D., Ms | Senior Vice President, Product | Leadership |
Windi Hary | Chief Regulatory And Quality Officer | Leadership |
Ruby Gill | VP Of Product | Leadership |
Lalitha Kosuri | Manager, Software Quality Assurance | Team |
David Smith | Senior Program Manager | Team |
Vivian Zhang, MPH | Marketing Manager | Team |
Amy Kruglak, SPHR | SVP Of People & Leadership Development | Team |
Divya Inamdar | Product Owner | Team |
Svetlana Napris | SQA Engineer | Team |
Complete people profiles for Elucid
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Elucid
3 dated milestones of Elucid across 13 years, from founding to its latest funding, stage changes and deals.
- Founded Elucid is founded.
- Funding First funding round of $375K.
- Funding Latest funding round, Series D, of $55.0M.
Competitors of Elucid
Elucid has 2 listed competitors in our database, 1 of them funded. They include Vista.ai and Dyad Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| vista.ai | 2012 | Palo Alto, United States | $8.7M | 13 | AI-guided software is utilized to automate MRI exams for clinicians. | |
| dyadmed.com | 2016 | Boston, United States | AI-based automated interpretation of medical images is provided. |
Detailed competitors of Elucid
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Elucid
The website of Elucid (elucid.com) receives about 5.6K visits a month.
- Monthly visits5.6K
▲ 23.9% vs previous month
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Elucid (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Elucid
Complete news archive for Elucid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Elucid
Elucid was founded in 2013.
Elucid is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Blake Richards is the CEO of Elucid, as recorded in our data.
Elucid is a funded company, having raised a total of $206.87M across 8 funding rounds to date. The company's 1st funding round was a Seed of $375K, raised on Aug 2013.
Elucid was founded in 2013 and is headquartered in Boston, United States. AI-driven software for arterial analysis is provided to healthcare providers, supporting clinical diagnostic processes. Features are included for clinical research, personalized patient care, and stroke prediction. Operations focus on medical imaging and diagnostic tools within the health technology sector.
Elucid's top competitors include Vista.ai and Dyad Medical.
Elucid has 9 investors. Key investors include Elevage Medical Technologies, MedTex Ventures, IAG Capital Partners, BlueStone Venture Partners, and Biovision Ventures.
Elucid operates through Elucid Bioimaging Inc..
